Crystal Structure of Glucokinase Regulatory Protein

Alexander Pautsch(Boehringer Ingelheim (Germany)), Stefan G. Kauschke(Boehringer Ingelheim (Germany)), Wolfgang Rist(University of Applied Sciences Biberach), N. Stadler(Boehringer Ingelheim (Germany)), Gisela Schnapp(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), D.J. Reinert(Boehringer Ingelheim (Germany)), Armin Heckel(Boehringer Ingelheim (Germany)), Adelheid Löhle(Boehringer Ingelheim (Germany)), Martin Lenter(Boehringer Ingelheim (Germany)), Lucia Glocker, A. Berg(Boehringer Ingelheim (Germany))
DORA PSI (Paul Scherrer Institute)
January 1, 2013
Cited by 0

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285